Subscribe to our Newsletters !!
Cell therapy is a medical breakthrough in addressi
Chromium, a transition metal with profound pharmac
Few names in the medical history have had a profou
We are pleased to announce that we have recently e
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Mi
The organization has gotten last endorsement from the US Food and Drug Administration (USFDA) to showcase its item which is a conventional form of Gleevec tablets, Zydus Cadila said in an announcement.
The Ahmedabad-based firm has gotten endorsement to advertise the medication in qualities of 100 mg and 400 mg, it included.
“This medicine is utilized to treat particular sorts of leukemia (blood malignant growth), bone marrow issue, skin disease and tumors of the stomach and stomach related framework,” the medication producer said.
The medication will be made at the gathering’s definition fabricating office at the SEZ, in Ahmedabad.
The organization said it currently has 285 endorsements and has so far recorded more than 386 abbriviated new medication application (ANDAs) since the beginning of the documenting procedure in 2003-04.